Arvinas Inc reports results for the quarter ended December 31 - Earnings Summary

Arvinas

11/02/2025 14:32

* Arvinas Inc  ARVN.OQ  reported a quarterly adjusted loss
of 63
cents​​ per share for the quarter ended December 31, higher than
the same quarter last year, when the company reported EPS of
$-2.53.  The mean expectation of twenty one analysts for the
quarter was for a loss of $1.02 per share. Wall Street expected
results to range from $-1.87 to -22 cents per share.
    * Revenue rose 237.4% to $59.20 million from a year ago;
analysts
expected $65.28 million. 
    * Arvinas Inc's reported EPS for the quarter was a loss
of 63
cents​.
    * The company reported a quarterly loss of $45.1 million.
    * Arvinas Inc shares had fallen by 1.0% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 6.1%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 20 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Arvinas Inc is
$60.00 
This summary was machine generated from LSEG data February 11 at
02:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -1.02          -0.63          Beat
 Sep. 30 2024      -0.96          -0.68          Beat
 Jun. 30 2024      -0.86          -0.49          Beat
 Mar. 31 2024      -1.42          -0.97          Beat